1. Home
  2. NAOV vs KTTA Comparison

NAOV vs KTTA Comparison

Compare NAOV & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAOV
  • KTTA
  • Stock Information
  • Founded
  • NAOV 2003
  • KTTA 2020
  • Country
  • NAOV United States
  • KTTA United States
  • Employees
  • NAOV N/A
  • KTTA N/A
  • Industry
  • NAOV Industrial Specialties
  • KTTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAOV Health Care
  • KTTA Health Care
  • Exchange
  • NAOV Nasdaq
  • KTTA Nasdaq
  • Market Cap
  • NAOV 2.4M
  • KTTA 2.6M
  • IPO Year
  • NAOV N/A
  • KTTA 2021
  • Fundamental
  • Price
  • NAOV $0.38
  • KTTA $1.30
  • Analyst Decision
  • NAOV
  • KTTA
  • Analyst Count
  • NAOV 0
  • KTTA 0
  • Target Price
  • NAOV N/A
  • KTTA N/A
  • AVG Volume (30 Days)
  • NAOV 6.7M
  • KTTA 3.3M
  • Earning Date
  • NAOV 04-07-2025
  • KTTA 03-28-2025
  • Dividend Yield
  • NAOV N/A
  • KTTA N/A
  • EPS Growth
  • NAOV N/A
  • KTTA N/A
  • EPS
  • NAOV N/A
  • KTTA N/A
  • Revenue
  • NAOV $3,291,000.00
  • KTTA N/A
  • Revenue This Year
  • NAOV N/A
  • KTTA N/A
  • Revenue Next Year
  • NAOV N/A
  • KTTA N/A
  • P/E Ratio
  • NAOV N/A
  • KTTA N/A
  • Revenue Growth
  • NAOV 227.79
  • KTTA N/A
  • 52 Week Low
  • NAOV $0.36
  • KTTA $1.25
  • 52 Week High
  • NAOV $1.27
  • KTTA $9.25
  • Technical
  • Relative Strength Index (RSI)
  • NAOV 39.60
  • KTTA 30.34
  • Support Level
  • NAOV $0.36
  • KTTA $1.32
  • Resistance Level
  • NAOV $0.71
  • KTTA $1.38
  • Average True Range (ATR)
  • NAOV 0.06
  • KTTA 0.26
  • MACD
  • NAOV -0.00
  • KTTA -0.05
  • Stochastic Oscillator
  • NAOV 6.19
  • KTTA 1.92

About NAOV NanoVibronix Inc.

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.

Share on Social Networks: